VBI Vaccines Inc (NASDAQ:VBIV)
| 0.6713 Delayed Data As of 3:59pm ET |  +0.0453 / +7.24%Today’s Change | 0.59 Today|||52-Week Range 23.70 | -94.28% Year-to-Date |
Latest VBIV News | Press Releases
No recent news for VBI Vaccines Inc.
Today’s Trading
| Previous close | 0.63 |
| Today’s open | 0.69 |
| Day’s range | 0.66 - 0.74 |
| Volume | 42,037 |
| Average volume (3 months) | 1,007,652 |
| Market cap | $16.0M |
Data as of 3:59pm ET, 09/27/2023
Growth & Valuation
| Earnings growth (last year) | -60.35% |
| Earnings growth (this year) | +54.95% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +71.47% |
| P/E ratio | NM |
| Price/Sales | 93.35 |
| Price/Book | 0.09 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ARAVAravive Inc | -0.00 | -3.48% |
| VBLTVascular Biogenics L... | +0.00 | +1.35% |
| CANFCan Fite Biopharma L... | +0.05 | +1.93% |
| ALBTAvalon Globocare Cor... | 0.00 | 0.00% |
Data as of 3:59pm ET, 09/27/2023
Financials
| Next reporting date | November 6, 2023 |
| EPS forecast (this quarter) | -$0.18 |
| Annual revenue (last year) | $1.1M |
| Annual profit (last year) | -$113.3M |
| Net profit margin | -10,471.63% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
